Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




New Biosensor Detects Extremely Low Bacteria Concentrations

By HospiMedica International staff writers
Posted on 04 Aug 2009
A novel carbon-nanotube based potentiometric biosensor is able to detect extremely low concentrations of microorganisms quickly, easily, and reliably. More...


The new biosensor, developed by researchers at the Universitat Rovira i Virgili (Tarragona, Spain) is able to detect ultralow concentrations of bacteria with the aid of specific aptamer sensors. Electrochemical measurements of test solutions are carried out by means of carbon nanotubes that are equipped with bacteria-specific aptamers that serve as binding sites.

The aptamers are anchored the to carbon nanotubes by means of additional functional groups, which are then deposited onto an electrode in an ultrathin layer. In the absence of bacteria, the aptamers fit closely against the walls of the carbon nanotubes. But when the biosensor is put into a specific microorganism-containing sample, the microbes stick to the aptamers; this adhesion influences the interaction between the aptamers and the nanotubes, changing the electrode voltage within seconds. When using the new biosensor, equipped with specific aptamers for Salmonella typhi, the researchers were able to detect extremely low concentrations of the typhus-inducing bacteria. In fact, the researchers were able to detect a bacterial concentration equivalent to 1 Salmonella bacterium in five milliliters of medium, and quantitative measurements were possible down to a low concentration of about 1,000 Salmonella per milliliter. The novel biosensor was described in the July 2009 issue of the journal Angewandte Chemie.

"This biosensor is specific; it does not react to bacteria other than Salmonella typhi,” said study authors Jordi Riu and F. Xavier Rius, of the department of analytic and organic chemistry. "Our new technique makes the detection of microorganisms as fast and simple as the measurement of pH value.”

Aptamers are synthetic short DNA or RNA strands that can be designed and made to bind a specific target molecule. They are composed of oligonucleic acid or peptide molecules that can be used for both basic research and clinical purposes as macromolecular drugs. Aptamers can be also be combined with ribozymes to self-cleave in the presence of their target molecule.

Related Links:

Universitat Rovira i Virgili



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Pressure Guidewire
SavvyWire
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.